Biotech, Clinical Research, Pharmaceutical News & Jobs...
Current status: normal - monitoring
Number of users monitoring this page: 0
Most recent sizable change (text, html) : 2012-05-18 20:25
Most recent change (text, html) : 2012-05-20 18:43
Last checked for changes: 2012-05-20 18:43
ChangeDetection started monitoring: 2007-08-07 18:43
|
monitor this page
summary of most recent changes
|
View changes:
2012-05-18 20:25
337 new words, 363 deleted words, 55% change
|
|
... Real Estate Business Opportunities ThursdayFriday, May 1718, 2012 Human Genome Sciences, Allergan Inc. ( HGSI AGN ) Board Adopts Poison Pill Antitakeover Planto Build R&D Plant, Add 400 Jobs in Talks With Potential Suitors New Jersey More... Kythera Biopharmaceuticals Kleiner Perkins Caufield & Byers Files for Launches New $86.3 Milion IPO 525 Million Venture Fund More... Agilent Technologies, Inc ...
Real Estate Business Opportunities Friday, May 18, 2012 Allergan Inc. ( AGN ) to Build R&D Plant, Add 400 Jobs in New Jersey More... Kleiner Perkins Caufield & Byers Launches New $525 Million Venture Fund More... Johnson & Johnson ( JNJ ) Recalls Nearly 54,000 Packages of Imodium More... Osiris Therapeutics, Inc. ( OSIR ) Wins Canadian Approval for First Stem-Cell Therapy More... GlaxoSmithKline ( ...
Real Estate Business Opportunities Thursday, May 17, 2012 Human Genome Sciences, Inc. ( HGSI ) Board Adopts Poison Pill Antitakeover Plan, ... in Talks With Potential Suitors More... Kythera Biopharmaceuticals Files for $86.3 Milion IPO More... Agilent Technologies, Inc ... Clara, California) ( A ) to Acquire Dako A/S for $2.2 Billion More... Pfizer Inc. ( PFE )'s Popular Antibiotic ... Risk of Sudden Death ...
more...
|
|
View changes:
2012-05-17 18:43
403 new words, 473 deleted words, 62% change
|
|
... Real Estate Business Opportunities WednesdayThursday, May 1617, 2012 Roche Human Genome Sciences, Inc. ( RHHBY HGSI )'s Genentech ( RHHBY ) to Take Part Board Adopts Poison Pill Antitakeover Plan, in First-ever Alzheimer's Prevention Trial Talks With Potential Suitors More... Merck KGaA Kythera Biopharmaceuticals ( MKGAF.PK ) Targets Files for $385 Million in Cost ... as Geneva Protests Continue ...
Real Estate Business Opportunities Thursday, May 17, 2012 Human Genome Sciences, Inc. ( HGSI ) Board Adopts Poison Pill Antitakeover Plan, in Talks With Potential Suitors More... Kythera Biopharmaceuticals Files for $86.3 Milion IPO More... Agilent Technologies, Inc ... ) ( A ) to Acquire Dako A/S for $2.2 Billion More... Pfizer Inc. ( PFE )'s Popular Antibiotic ... Risk of Sudden Death More... Tolerability of Aveo / ...
Real Estate Business Opportunities Wednesday, May 16, 2012 Roche ( RHHBY )'s Genentech ( RHHBY ) to Take Part in First-ever Alzheimer's Prevention Trial More... Merck KGaA ( MKGAF.PK ) Targets $385 Million in Cost ... as Geneva Protests Continue More... Piramal Healthcare Limited to Buy US Drug Data Firm for $635 Million More... Pfizer Inc. ( PFE ) Cuts 50 Jobs at Estrogen Facility More... Pfizer Inc. ( ...
more...
|
|
View changes:
2012-05-16 18:43
438 new words, 390 deleted words, 60% change
|
|
... Real Estate Business Opportunities TuesdayWednesday, May 1516, 2012 AstraZeneca PLC Roche ( AZN RHHBY )'s Genentech ( RHHBY ) Slashes 400 More Jobs to Take Part in Sweden First-ever Alzheimer's Prevention Trial More... Cornerstone Therapeutics Inc. Merck KGaA to Acquire ( EKR Therapeutics, IncMKGAF. PK for ) Targets $125 385 Million Cash, Plus $25 Million in Milestones Cost Cuts by 2014 as Geneva Protests Continue ...
Real Estate Business Opportunities Wednesday, May 16, 2012 Roche ( RHHBY )'s Genentech ( RHHBY ) to Take Part in First-ever Alzheimer's Prevention Trial More... Merck KGaA ( MKGAF. PK ) Targets $385 Million ... in Cost Cuts by 2014 as Geneva Protests Continue More... Piramal Healthcare Limited to ... Buy US Drug Data Firm for $635 Million More... Pfizer Inc. ( PFE ) Cuts 50 Jobs at Estrogen Facility ...
Real Estate Business Opportunities Tuesday, May 15, 2012 AstraZeneca PLC ( AZN ) Slashes 400 More Jobs in Sweden More... Cornerstone Therapeutics Inc. to Acquire EKR Therapeutics, Inc. for $125 Million Cash, Plus $25 Million in Milestones More... GlaxoSmithKline ( GSK ) to Fully Buy Cellzome AG for $99 Million More... Watson Pharmaceuticals, Inc. ( WPI ) Shuts Down Groveport Warehouse, Lays Off 55 ...
more...
|
|
View changes:
2012-05-15 18:43
326 new words, 313 deleted words, 50% change
|
|
... Real Estate Business Opportunities MondayTuesday, May 1415, 2012 OncoMed PharmaceuticalsAstraZeneca PLC ( AZN ... to Acquire EKR Therapeutics, Inc. Files for $115 125 Million IPO Cash, Plus $25 Million in Milestones More... Roche GlaxoSmithKline ( RHHBY GSK ) Bets on an Alzheimer's Drug to Fully Buy Cellzome ... for $99 Million More... Gilead SciencesWatson Pharmaceuticals, Inc. ( GILD WPI )' HIV Quad Pill Wins Backing From ...
Real Estate Business Opportunities Tuesday, May 15, 2012 AstraZeneca PLC ( AZN ... to Acquire EKR Therapeutics, Inc. ... for $125 Million Cash, Plus $25 Million in Milestones More... GlaxoSmithKline ( GSK ) to Fully Buy Cellzome ... for $99 Million More... Watson Pharmaceuticals, Inc. ( WPI ) Shuts Down Groveport ... , Lays Off 55 More... Hospira, Inc. ( HSP ) Recalls Pain Drug Cartridges More... Furiex Pharmaceuticals...
Real Estate Business Opportunities Monday, May 14, 2012 OncoMed Pharmaceuticals, Inc. Files for $115 Million IPO More... Roche ( RHHBY ) Bets on an Alzheimer's Drug More... Gilead Sciences, Inc. ( GILD )' HIV Quad Pill Wins Backing From FDA Advisers More... FDA Says Unsure if Novartis AG ( NVS ) MS Pill Caused Deaths More... Maxygen, Inc. ( MAXY ) Gets $30 Million Payment From Bayer HealthCare ( BAY ...
more...
|
|
View changes:
2012-05-14 19:02
350 new words, 393 deleted words, 56% change
|
|
... Real Estate Business Opportunities SundayMonday, May 1314, 2012 GoingOncoMed Pharmaceuticals, Going, Gone. Pfizer Inc. ( Files for $115 Million IPO PFE ) Eliminates Pensions More... Arena Pharmaceuticals, Inc. Roche ( ARNA RHHBY ) Wins Positive FDA Panel Vote for Obesity Bets on an Alzheimer's Drug More... Gilead ... . ( GILD )'s HIV Quad Pill Wins U.S. Panel Backing to Prevent HIV From FDA Advisers ...
Real Estate Business Opportunities Monday, May 14, 2012 OncoMed Pharmaceuticals, ... Inc. Files for $115 Million IPO More... Roche ( RHHBY ) Bets on an Alzheimer's Drug More... Gilead ... . ( GILD )'HIV Quad Pill Wins ... Backing From FDA Advisers More... FDA Says Unsure if Novartis AG ( NVS ) MS Pill Caused Deaths More... Maxygen, Inc. ( MAXY ) Gets $30 Million Payment From Bayer HealthCare ( BAY ...
Real Estate Business Opportunities Sunday, May 13, 2012 Going, Going, Gone. Pfizer Inc. ( PFE ) Eliminates Pensions More... Arena Pharmaceuticals, Inc. ( ARNA ) Wins Positive FDA Panel Vote for Obesity Drug More... Gilead ... . ( GILD )'s Pill Wins U.S. Panel Backing to Prevent HIV More... AMAG Pharmaceuticals, Inc. ( AMAG ) Slumps as it Shelves Possible Sale More... Rib-X Pharmaceuticals, Inc. Postpones IPO After Slashing Price by 50 Pct ...
more...
|
link to this change log
Changes to the page www.biospace.com are logged on this page as they are detected. You can link to this log
by pasting the HTML below into your page. It produces a link which looks like this: change log
|
|
